259 related articles for article (PubMed ID: 30187999)
1. Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway.
Ni Y; Wang X; Yin X; Li Y; Liu X; Wang H; Liu X; Zhang J; Gao H; Shi B; Zhao S
J Cell Mol Med; 2018 Nov; 22(11):5450-5467. PubMed ID: 30187999
[TBL] [Abstract][Full Text] [Related]
2. FAK contributes to proteinuria in hypercholesterolaemic rats and modulates podocyte F-actin re-organization via activating p38 in response to ox-LDL.
Hu M; Fan M; Zhen J; Lin J; Wang Q; Lv Z; Wang R
J Cell Mol Med; 2017 Mar; 21(3):552-567. PubMed ID: 27704688
[TBL] [Abstract][Full Text] [Related]
3. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
4. Activation of integrin β1-focal adhesion kinase-RasGTP pathway plays a critical role in TGF beta1-induced podocyte injury.
Zhang YJ; Tian ZL; Yu XY; Zhao XX; Yao L
Cell Signal; 2013 Dec; 25(12):2769-79. PubMed ID: 24036212
[TBL] [Abstract][Full Text] [Related]
5. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.
Pengal R; Guess AJ; Agrawal S; Manley J; Ransom RF; Mourey RJ; Benndorf R; Smoyer WE
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F509-19. PubMed ID: 21613416
[TBL] [Abstract][Full Text] [Related]
7. Integrin α6β4 requires plectin and vimentin for adhesion complex distribution and invasive growth.
Qi L; Knifley T; Chen M; O'Connor KL
J Cell Sci; 2022 Jan; 135(2):. PubMed ID: 34897465
[TBL] [Abstract][Full Text] [Related]
8. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
9. PKD2 and RSK1 Regulate Integrin β4 Phosphorylation at Threonine 1736.
Te Molder L; Sonnenberg A
PLoS One; 2015; 10(11):e0143357. PubMed ID: 26580203
[TBL] [Abstract][Full Text] [Related]
10. High-content screening assay-based discovery of paullones as novel podocyte-protective agents.
Lee HW; Arif E; Altintas MM; Quick K; Maheshwari S; Plezia A; Mahmood A; Reiser J; Nihalani D; Gupta V
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F280-F292. PubMed ID: 29046299
[TBL] [Abstract][Full Text] [Related]
11. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients.
Wang H; Zheng C; Xu X; Zhao Y; Lu Y; Liu Z
Nephrology (Carlton); 2018 May; 23(5):418-429. PubMed ID: 28407405
[TBL] [Abstract][Full Text] [Related]
13. 5'-AMP-activated protein kinase attenuates adriamycin-induced oxidative podocyte injury through thioredoxin-mediated suppression of the apoptosis signal-regulating kinase 1-P38 signaling pathway.
Gao K; Chi Y; Sun W; Takeda M; Yao J
Mol Pharmacol; 2014 Mar; 85(3):460-71. PubMed ID: 24378334
[TBL] [Abstract][Full Text] [Related]
14. Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin.
Qiu Y; Lei C; Zeng J; Xie Y; Cao Y; Yuan Q; Su H; Zhang Z; Zhang C
Mol Ther; 2023 Nov; 31(11):3337-3354. PubMed ID: 37689970
[TBL] [Abstract][Full Text] [Related]
15. Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy.
Ye M; Zheng J; Chen X; Chen X; Wu X; Lin X; Liu Y
Mol Med Rep; 2015 Nov; 12(5):7471-8. PubMed ID: 26459042
[TBL] [Abstract][Full Text] [Related]
16. α-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury.
Liu H; Gao X; Xu H; Feng C; Kuang X; Li Z; Zha X
Nephrology (Carlton); 2012 Nov; 17(8):669-75. PubMed ID: 22804863
[TBL] [Abstract][Full Text] [Related]
17. PP2A protects podocytes against Adriamycin-induced injury and epithelial-to-mesenchymal transition via suppressing JIP4/p38-MAPK pathway.
Lu Z; Zhu X; Ye Y; Fu H; Mao J
Cytotechnology; 2021 Oct; 73(5):697-713. PubMed ID: 34629746
[TBL] [Abstract][Full Text] [Related]
18. Hirudin attenuates puromycin aminonucleoside-induced glomerular podocyte injury by inhibiting MAPK-mediated endoplasmic reticulum stress.
Long C; Lin Q; Mo J; Xiao Y; Xie Y
Drug Dev Res; 2022 Jun; 83(4):1047-1056. PubMed ID: 35277865
[TBL] [Abstract][Full Text] [Related]
19. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-like 3 induces podocyte F-actin rearrangement through integrin α(V)β₃/FAK/PI3K pathway-mediated Rac1 activation.
Lin Y; Rao J; Zha XL; Xu H
Biomed Res Int; 2013; 2013():135608. PubMed ID: 24294595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
